Expression of von Willebrand factor, an endothelial cell marker, is up- regulated by angiogenesis factors: A potential method for objective assessment of tumor angiogenesis

Lucia Zanetta, Stuart G. Marcus, Julie Vasile, Michael Dobryansky, Henry Cohen, Kenneth Eng, Peter Shamamian, Paolo Mignatti

Research output: Contribution to journalArticle

114 Citations (Scopus)

Abstract

von Willebrand factor (vWF), a glycoprotein produced uniquely by endothelial cells and megakaryocytes, is routinely used to identify vessels in tissue sections. Vessel density in tumor specimens, as determined by immuno-histochemical staining for vWF or other endothelial cell markers, is a negative prognostic factor for many solid tumors, vWF is heterogeneously distributed throughout the vasculature, transcriptional control in response to the tissue microenvironment being responsible for local variations in endothelial cell levels of vWF. Here, we report that fibroblast growth factor-2 and vascular endothelial growth factor, potent angiogenesis inducers expressed in a variety of tumors, up-regulate expression of vWF mRNA and protein in cultured endothelial cells with a synergistic effect. Our data support the measurement of vWF mRNA in tumors to detect activated endothelium or angiogenesis. For this purpose, we developed a semiquantitative RT-PCR for vWF mRNA. Preliminary results obtained with specimens from colon carcinoma and the corresponding normal colonic mucosa showed higher vWF mRNA levels in most tumors than in their normal counterparts. The differences in vWF mRNA levels were much larger than the differences in vessel counts between a tumor and the corresponding normal mucosa, indicating that high vWF mRNA levels in tumors may indeed be an early sign of activation of the endothelium. The rapidity, objectivity, sensitivity and specificity of this technique make it suitable for routine clinical application to identify aggressive, highly angiogenic tumors.

Original languageEnglish (US)
Pages (from-to)281-288
Number of pages8
JournalInternational Journal of Cancer
Volume85
Issue number2
DOIs
StatePublished - Jan 15 2000
Externally publishedYes

Fingerprint

Angiogenesis Inducing Agents
von Willebrand Factor
Endothelial Cells
Neoplasms
Messenger RNA
Endothelium
Mucous Membrane
Megakaryocytes
Fibroblast Growth Factor 2
Vascular Endothelial Growth Factor A
Cultured Cells
Glycoproteins
Colon
Up-Regulation
Staining and Labeling
Carcinoma
Sensitivity and Specificity
Polymerase Chain Reaction

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Expression of von Willebrand factor, an endothelial cell marker, is up- regulated by angiogenesis factors : A potential method for objective assessment of tumor angiogenesis. / Zanetta, Lucia; Marcus, Stuart G.; Vasile, Julie; Dobryansky, Michael; Cohen, Henry; Eng, Kenneth; Shamamian, Peter; Mignatti, Paolo.

In: International Journal of Cancer, Vol. 85, No. 2, 15.01.2000, p. 281-288.

Research output: Contribution to journalArticle

Zanetta, Lucia ; Marcus, Stuart G. ; Vasile, Julie ; Dobryansky, Michael ; Cohen, Henry ; Eng, Kenneth ; Shamamian, Peter ; Mignatti, Paolo. / Expression of von Willebrand factor, an endothelial cell marker, is up- regulated by angiogenesis factors : A potential method for objective assessment of tumor angiogenesis. In: International Journal of Cancer. 2000 ; Vol. 85, No. 2. pp. 281-288.
@article{2ffde020ce6e490bbfa1d0e223aa9036,
title = "Expression of von Willebrand factor, an endothelial cell marker, is up- regulated by angiogenesis factors: A potential method for objective assessment of tumor angiogenesis",
abstract = "von Willebrand factor (vWF), a glycoprotein produced uniquely by endothelial cells and megakaryocytes, is routinely used to identify vessels in tissue sections. Vessel density in tumor specimens, as determined by immuno-histochemical staining for vWF or other endothelial cell markers, is a negative prognostic factor for many solid tumors, vWF is heterogeneously distributed throughout the vasculature, transcriptional control in response to the tissue microenvironment being responsible for local variations in endothelial cell levels of vWF. Here, we report that fibroblast growth factor-2 and vascular endothelial growth factor, potent angiogenesis inducers expressed in a variety of tumors, up-regulate expression of vWF mRNA and protein in cultured endothelial cells with a synergistic effect. Our data support the measurement of vWF mRNA in tumors to detect activated endothelium or angiogenesis. For this purpose, we developed a semiquantitative RT-PCR for vWF mRNA. Preliminary results obtained with specimens from colon carcinoma and the corresponding normal colonic mucosa showed higher vWF mRNA levels in most tumors than in their normal counterparts. The differences in vWF mRNA levels were much larger than the differences in vessel counts between a tumor and the corresponding normal mucosa, indicating that high vWF mRNA levels in tumors may indeed be an early sign of activation of the endothelium. The rapidity, objectivity, sensitivity and specificity of this technique make it suitable for routine clinical application to identify aggressive, highly angiogenic tumors.",
author = "Lucia Zanetta and Marcus, {Stuart G.} and Julie Vasile and Michael Dobryansky and Henry Cohen and Kenneth Eng and Peter Shamamian and Paolo Mignatti",
year = "2000",
month = "1",
day = "15",
doi = "10.1002/(SICI)1097-0215(20000115)85:2<281::AID-IJC21>3.0.CO;2-3",
language = "English (US)",
volume = "85",
pages = "281--288",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Expression of von Willebrand factor, an endothelial cell marker, is up- regulated by angiogenesis factors

T2 - A potential method for objective assessment of tumor angiogenesis

AU - Zanetta, Lucia

AU - Marcus, Stuart G.

AU - Vasile, Julie

AU - Dobryansky, Michael

AU - Cohen, Henry

AU - Eng, Kenneth

AU - Shamamian, Peter

AU - Mignatti, Paolo

PY - 2000/1/15

Y1 - 2000/1/15

N2 - von Willebrand factor (vWF), a glycoprotein produced uniquely by endothelial cells and megakaryocytes, is routinely used to identify vessels in tissue sections. Vessel density in tumor specimens, as determined by immuno-histochemical staining for vWF or other endothelial cell markers, is a negative prognostic factor for many solid tumors, vWF is heterogeneously distributed throughout the vasculature, transcriptional control in response to the tissue microenvironment being responsible for local variations in endothelial cell levels of vWF. Here, we report that fibroblast growth factor-2 and vascular endothelial growth factor, potent angiogenesis inducers expressed in a variety of tumors, up-regulate expression of vWF mRNA and protein in cultured endothelial cells with a synergistic effect. Our data support the measurement of vWF mRNA in tumors to detect activated endothelium or angiogenesis. For this purpose, we developed a semiquantitative RT-PCR for vWF mRNA. Preliminary results obtained with specimens from colon carcinoma and the corresponding normal colonic mucosa showed higher vWF mRNA levels in most tumors than in their normal counterparts. The differences in vWF mRNA levels were much larger than the differences in vessel counts between a tumor and the corresponding normal mucosa, indicating that high vWF mRNA levels in tumors may indeed be an early sign of activation of the endothelium. The rapidity, objectivity, sensitivity and specificity of this technique make it suitable for routine clinical application to identify aggressive, highly angiogenic tumors.

AB - von Willebrand factor (vWF), a glycoprotein produced uniquely by endothelial cells and megakaryocytes, is routinely used to identify vessels in tissue sections. Vessel density in tumor specimens, as determined by immuno-histochemical staining for vWF or other endothelial cell markers, is a negative prognostic factor for many solid tumors, vWF is heterogeneously distributed throughout the vasculature, transcriptional control in response to the tissue microenvironment being responsible for local variations in endothelial cell levels of vWF. Here, we report that fibroblast growth factor-2 and vascular endothelial growth factor, potent angiogenesis inducers expressed in a variety of tumors, up-regulate expression of vWF mRNA and protein in cultured endothelial cells with a synergistic effect. Our data support the measurement of vWF mRNA in tumors to detect activated endothelium or angiogenesis. For this purpose, we developed a semiquantitative RT-PCR for vWF mRNA. Preliminary results obtained with specimens from colon carcinoma and the corresponding normal colonic mucosa showed higher vWF mRNA levels in most tumors than in their normal counterparts. The differences in vWF mRNA levels were much larger than the differences in vessel counts between a tumor and the corresponding normal mucosa, indicating that high vWF mRNA levels in tumors may indeed be an early sign of activation of the endothelium. The rapidity, objectivity, sensitivity and specificity of this technique make it suitable for routine clinical application to identify aggressive, highly angiogenic tumors.

UR - http://www.scopus.com/inward/record.url?scp=0034650797&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034650797&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1097-0215(20000115)85:2<281::AID-IJC21>3.0.CO;2-3

DO - 10.1002/(SICI)1097-0215(20000115)85:2<281::AID-IJC21>3.0.CO;2-3

M3 - Article

C2 - 10629090

AN - SCOPUS:0034650797

VL - 85

SP - 281

EP - 288

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 2

ER -